Notice: This application will enforce Multi-factor authentication (MFA) for NIH users beginning the evening of Wed Aug 3rd.
NIH | National Cancer Institute | NCI Wiki  

Concomitant Medications NCI CRF Standards:  Round 3

Concomitant medication is combining two or more treatment regimes when treating diseases.  The Concomitant Medications module was one of the group of variables included in the third round of the CRF Harmonization and Standardization Initiative.  The Concomitant Medications module includes harmonized variables related to Concomitant Medications recommended for collection on all NCI sponsored clinical trials.

Downloads

Concomitant Medications NCI CRF Standards created on October 19th, 2018

Concomitant Medications NCI CRF Standards created on June 21st, 2016

Concomitant Medications NCI CRF Standards created on September 5th, 2014


Changes made from September 5th, 2014 to October 19, 2018

ModuleCDECDE Public IDCDE VersionChange
Concomitant MedicationsFrequency
v2.0
  1. Frequency CDE 2003322 - Added PV - every month for 3 months
  2. Dose CDE 2182728 was versioned from 2.0 to 3.0 – updated to the new version
Concomitant Medications

Frequency

Indication

Unit of Measure

2003322

2003870

3028750

v4.0

v4.0

v1.0

  1. Frequency CDE 2003322 - Added PV - q6wk
  2. Indication CDE 2003870 - Added PVs - Autoimmune Toxicity, Depressed level of consciousness
  3. Unit of Measure CDE 3028750 - Added PVs - 10^6{TCID50}, 10^7{TCID50}, 10^8{TCID50}


Status

      status diagram showing pilot status

Metrics

CRF Stars:  Working Group Membership

* Represents working group leads

  • No labels